Danish devices association urges authorities to deter reuse firm
This article was originally published in Clinica
Executive Summary
Denmark's state serum institute (SSI) has denied suggestions that it has in any way approved the practices of German medical devices reprocessing company Vanguard. This statement comes despite the publication of a report by SSI in which it claims that the resterilisation of single-use devices is defensible "in certain cases". In reply to a letter from Medicoidustrien, the medical devices industry association, SSI said that it did not even have the authority to approve such procedures.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.